Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
- PMID: 2190280
Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
Abstract
At present the pathogenesis of diabetic nephropathy remains unresolved. Clearly lack of insulin, with its associated disorders of carbohydrate, protein, and/or lipid metabolism, initiates the process which eventually leads to the characteristic histologic picture of diabetic nephropathy. The disturbance in cellular metabolism per se could directly injure the kidney by altering the energy needs of the cell or by leading to the accumulation of cellular toxins (ie, polyols) or by causing the deficiency of key cellular metabolites (ie, myoinositol). Elevation of the plasma glucose concentration enhances the glycosylation of proteins, which in turn can lead to glomerular basement membrane thickening, loss of charge selectivity, and direct cellular damage. The multiple disturbances in intermediary metabolism are associated with increased levels of and/or enhanced sensitivity to a variety of growth factors, including IGF-I and angiotensin, and this could lead to glomerular hypertrophy. An increase in the filtered load and subsequent reabsorption of electrolytes and metabolites also could contribute to renal hypertrophy. In all animal models of nephropathy, including diabetes, glomerular hypertrophy has been shown to be the best correlate of glomerular sclerosis, proteinuria, and progressive renal deterioration. The potential mechanisms by which glomerular hypertrophy can lead to renal histologic damage were discussed previously. By increasing the luminal diameter, glomerular hypertrophy also would be expected to augment wall tension and thereby increase intraglomerular pressure. Derangements in cellular metabolism or altered sensitivity to angiotensin also can directly elevate the intraglomerular pressure and lead to structural renal damage. In this schema, elevated intraglomerular pressure is but one of many pathogenic factors that contribute to the development of diabetic glomerulopathy and albuminuria. The precise role of increased glomerular pressure in the evolution of diabetic nephropathy remains uncertain at present. In rats, severe diabetic nephropathy can occur without an increase in Pgc, while in humans, hyperfiltration does not appear to be a predictor of proteinuria and renal dysfunction. Lastly, it is likely that a variety of other factors, including the coagulation system, plasma/cell lipid levels, prostaglandins, etc, also play a role in the pathogenesis of diabetic nephropathy. According to the outline presented in Figure 1, it is unlikely that any single factor will be sufficient to explain the development of diabetic glomerulosclerosis. Ultimately, the origin of diabetic nephropathy in IDDM must be traced to insulin lack, with its associated derangements in cellular metabolism. Therefore, the importance of tight glucose control should not be underemphasized.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Control of glomerular hyperfiltration and renal hypertrophy by an angiotensin converting enzyme inhibitor prevents the progression of renal damage in hypertensive diabetic rats.J Hypertens. 1999 Dec;17(12 Pt 2):1925-31. doi: 10.1097/00004872-199917121-00023. J Hypertens. 1999. PMID: 10703891
-
Renoprotective action of angiotensin-converting enzyme inhibition in diabetes mellitus.J Cardiovasc Pharmacol. 1992;19 Suppl 6:S19-24. doi: 10.1097/00005344-199219006-00004. J Cardiovasc Pharmacol. 1992. PMID: 1382160 Review.
-
Glomerular hemodynamic and structural alterations in experimental diabetes mellitus.FASEB J. 1988 May;2(8):2339-47. doi: 10.1096/fasebj.2.8.3282959. FASEB J. 1988. PMID: 3282959 Review.
-
Pathogenesis of diabetic glomerulopathy: hemodynamic considerations.Diabetes Metab Rev. 1988 Mar;4(2):163-77. doi: 10.1002/dmr.5610040206. Diabetes Metab Rev. 1988. PMID: 3281808 Review.
-
[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].Presse Med. 2002 Nov 9;31(36):1714-20. Presse Med. 2002. PMID: 12467154 Review. French.
Cited by
-
Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children.Pediatr Nephrol. 1995 Apr;9(2):154-8. doi: 10.1007/BF00860729. Pediatr Nephrol. 1995. PMID: 7794707
-
Effect of myo-inositol supplementation on the development of renal pathological changes in the Cohen diabetic (type 2) rat.Diabetologia. 1995 Aug;38(8):899-905. doi: 10.1007/BF00400577. Diabetologia. 1995. PMID: 7589874
-
Glycolytic lactate in diabetic kidney disease.JCI Insight. 2024 Jun 10;9(11):e168825. doi: 10.1172/jci.insight.168825. JCI Insight. 2024. PMID: 38855868 Free PMC article.
-
Glomerular structural and functional changes in a high-fat diet mouse model of early-stage Type 2 diabetes.Diabetologia. 2004 Sep;47(9):1541-9. doi: 10.1007/s00125-004-1489-1. Epub 2004 Aug 27. Diabetologia. 2004. PMID: 15338127
-
Salt, hypertension and renal disease: comparative medicine, models and real diseases.Postgrad Med J. 1994 Oct;70(828):686-94. doi: 10.1136/pgmj.70.828.686. Postgrad Med J. 1994. PMID: 7831161 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical